CN1309415C - 杀体内寄生虫组合物 - Google Patents

杀体内寄生虫组合物 Download PDF

Info

Publication number
CN1309415C
CN1309415C CNB018054005A CN01805400A CN1309415C CN 1309415 C CN1309415 C CN 1309415C CN B018054005 A CNB018054005 A CN B018054005A CN 01805400 A CN01805400 A CN 01805400A CN 1309415 C CN1309415 C CN 1309415C
Authority
CN
China
Prior art keywords
alkyl
spp
compositions
chmech2me
chme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB018054005A
Other languages
English (en)
Chinese (zh)
Other versions
CN1404397A (zh
Inventor
J·卡尔贝
M·特劳贝尔
G·冯萨姆森－希梅尔斯特杰纳
A·哈德尔
M·施特格曼
N·门克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of CN1404397A publication Critical patent/CN1404397A/zh
Application granted granted Critical
Publication of CN1309415C publication Critical patent/CN1309415C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNB018054005A 2000-02-22 2001-02-09 杀体内寄生虫组合物 Expired - Lifetime CN1309415C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008128.2 2000-02-22
DE10008128A DE10008128A1 (de) 2000-02-22 2000-02-22 Endoparasitizide Mittel

Publications (2)

Publication Number Publication Date
CN1404397A CN1404397A (zh) 2003-03-19
CN1309415C true CN1309415C (zh) 2007-04-11

Family

ID=7631886

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018054005A Expired - Lifetime CN1309415C (zh) 2000-02-22 2001-02-09 杀体内寄生虫组合物

Country Status (25)

Country Link
US (1) US20030125244A1 (OSRAM)
EP (1) EP1259250B1 (OSRAM)
JP (2) JP5596249B2 (OSRAM)
KR (1) KR100755414B1 (OSRAM)
CN (1) CN1309415C (OSRAM)
AR (2) AR028218A1 (OSRAM)
AT (1) ATE343394T1 (OSRAM)
AU (2) AU4060501A (OSRAM)
BR (1) BR0108562B1 (OSRAM)
CA (1) CA2400610C (OSRAM)
CZ (1) CZ300242B6 (OSRAM)
DE (2) DE10008128A1 (OSRAM)
DK (1) DK1259250T3 (OSRAM)
ES (1) ES2274871T3 (OSRAM)
HK (1) HK1054326B (OSRAM)
HU (1) HUP0204554A3 (OSRAM)
IL (2) IL150988A0 (OSRAM)
MX (1) MXPA02008210A (OSRAM)
NO (1) NO328949B1 (OSRAM)
NZ (1) NZ520856A (OSRAM)
PL (1) PL203999B1 (OSRAM)
PT (1) PT1259250E (OSRAM)
RU (1) RU2292905C2 (OSRAM)
WO (1) WO2001062268A1 (OSRAM)
ZA (1) ZA200205982B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104362A1 (de) * 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
EP1561820B1 (en) * 2002-11-12 2008-12-31 The Kitasato Institute Anthelmintic substance fki-1033 and process for producing the same
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
MX2011002166A (es) 2008-08-28 2011-04-07 Pfizer Derivados de dioxa-biciclo[3.2.1]octano-2,3,1-triol.
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
HRP20211041T1 (hr) 2015-05-20 2021-10-01 Boehringer Ingelheim Animal Health USA Inc. Anthelmintski depsipeptidni spojevi
RU2715556C2 (ru) 2015-12-28 2020-03-02 Мериал, Инк. Противогельминтные депсипептидные соединения
JP2020504710A (ja) 2016-11-16 2020-02-13 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
EP4013388A1 (en) 2019-08-14 2022-06-22 Vetoquinol SA Compositions comprising tigolaner for controlling parasites

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5717063A (en) * 1993-05-26 1998-02-10 Bayer Aktiengesellschaft Octacyclodepsipeptides having an endoparasiticidal action
US5821222A (en) * 1992-06-11 1998-10-13 Bayer Aktiengesellschaft Cyclic depsipeptides having 18 ring atoms for combating endoparasites

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
DE69331414T2 (de) * 1992-03-17 2002-08-08 Fujisawa Pharmaceutical Co., Ltd. Depsipeptide, herstellung und anwendung
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
WO1995021624A1 (en) * 1994-02-08 1995-08-17 Nippon Kayaku Kabushiki Kaisha High-concentration aureobasidin preparation in solution form
DE4417742A1 (de) * 1994-05-20 1995-11-23 Bayer Ag Nicht-systemische Bekämpfung von Parasiten
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
DE19545044A1 (de) * 1995-12-02 1997-06-05 Bayer Ag Endoparasitizide Mittel
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
JP4098474B2 (ja) * 1998-03-19 2008-06-11 メルク エンド カムパニー インコーポレーテッド 外部寄生虫侵入防除用硫黄ペンタフルオロフェニルピラゾール
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821222A (en) * 1992-06-11 1998-10-13 Bayer Aktiengesellschaft Cyclic depsipeptides having 18 ring atoms for combating endoparasites
US5717063A (en) * 1993-05-26 1998-02-10 Bayer Aktiengesellschaft Octacyclodepsipeptides having an endoparasiticidal action

Also Published As

Publication number Publication date
DE10008128A1 (de) 2001-08-23
BR0108562B1 (pt) 2013-03-05
RU2002125493A (ru) 2004-03-20
EP1259250A1 (de) 2002-11-27
CA2400610C (en) 2013-01-22
PL357551A1 (en) 2004-07-26
AR028218A1 (es) 2003-04-30
US20030125244A1 (en) 2003-07-03
HUP0204554A3 (en) 2005-05-30
JP5596249B2 (ja) 2014-09-24
CZ300242B6 (cs) 2009-03-25
CA2400610A1 (en) 2001-08-30
AU2001240605B2 (en) 2005-04-21
AR085989A2 (es) 2013-11-13
IL150988A0 (en) 2003-02-12
MXPA02008210A (es) 2003-01-28
NO328949B1 (no) 2010-06-28
HK1054326B (zh) 2007-11-09
JP2003523397A (ja) 2003-08-05
HUP0204554A2 (en) 2003-05-28
KR100755414B1 (ko) 2007-09-04
IL150988A (en) 2011-06-30
CZ20022867A3 (cs) 2003-01-15
PL203999B1 (pl) 2009-11-30
PT1259250E (pt) 2007-01-31
JP2012107024A (ja) 2012-06-07
ES2274871T3 (es) 2007-06-01
BR0108562A (pt) 2002-11-12
ATE343394T1 (de) 2006-11-15
NO20023976D0 (no) 2002-08-21
EP1259250B1 (de) 2006-10-25
WO2001062268A1 (de) 2001-08-30
DE50111315D1 (de) 2006-12-07
NO20023976L (no) 2002-10-21
NZ520856A (en) 2005-04-29
RU2292905C2 (ru) 2007-02-10
KR20020072577A (ko) 2002-09-16
ZA200205982B (en) 2003-07-28
AU4060501A (en) 2001-09-03
DK1259250T3 (da) 2007-02-26
HK1054326A1 (en) 2003-11-28
CN1404397A (zh) 2003-03-19

Similar Documents

Publication Publication Date Title
CN1142790C (zh) 杀内寄生虫组合物
CN1127294C (zh) 杀内/外寄生虫组合物
EP1694291B1 (de) Endoparasitizide mittel zur topischen applikation
JP2012107024A (ja) 殺内部寄生虫剤
CN1438879A (zh) 动物自愿摄取的杀体内寄生虫组合物
JP2013079268A (ja) 内部寄生虫駆除剤
CN100344281C (zh) 截短侧耳素衍生物在生产用于人和动物细菌感染的透皮治疗药物中的用途
WO2009156071A1 (de) Kombination von amidin-derivaten mit cyclischen depsipeptiden
CN1278735C (zh) 具有改进活性的环缩酚肽的晶型
CN101102785B (zh) 防止体内寄生虫垂直感染
CN1411335A (zh) 防治寄生昆虫幼虫的在皮肤上可使用的杀虫剂液体制剂
HK1102915B (en) Endoparasiticidal agents for topical application
HK1117041B (en) Prevention of vertical endoparasite infections
HK1075013B (en) Crystal modification of a cyclic depsipeptide having improved strength

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: BAYER ANIMAL HEALTH PROMOTION CO.,LTD.

Free format text: FORMER OWNER: BAYER AG

Effective date: 20091106

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20091106

Address after: Germany Leverkusen

Patentee after: Bayer Animal Health GmbH

Address before: Germany Leverkusen

Patentee before: Bayer Aktiengesellschaft

ASS Succession or assignment of patent right

Owner name: BAYER INTELLECTUAL PROPERTY GMBH

Free format text: FORMER OWNER: BAYER ANIMAL HEALTH GMBH

Effective date: 20130124

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20130124

Address after: German Monheim

Patentee after: Bayer Pharma Aktiengesellschaft

Address before: Germany Leverkusen

Patentee before: Bayer Animal Health GmbH

CX01 Expiry of patent term

Granted publication date: 20070411

CX01 Expiry of patent term